Can-Fite BioPharma Ltd. (TLV:CANF)
Israel flag Israel · Delayed Price · Currency is ILS · Price in ILA
1.500
0.00 (0.00%)
Apr 24, 2025, 5:24 PM IDT

Can-Fite BioPharma Ratios and Metrics

Millions ILS. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2015 - 2019
Period Ending
Apr '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
Market Capitalization
5857326912092
Upgrade
Market Cap Growth
77.98%77.98%-53.52%-42.86%29.93%106.23%
Upgrade
Enterprise Value
30392307657
Upgrade
Last Close Price
0.010.020.030.080.150.20
Upgrade
PS Ratio
23.7923.0911.9024.0645.2037.63
Upgrade
PB Ratio
2.952.861.424.362.684.73
Upgrade
P/TBV Ratio
2.952.861.424.362.684.73
Upgrade
EV/Sales Ratio
12.2415.930.6510.6328.7023.35
Upgrade
Debt / Equity Ratio
0.020.020.010.010.010.01
Upgrade
Asset Turnover
0.070.070.080.060.060.09
Upgrade
Quick Ratio
3.843.844.423.197.016.57
Upgrade
Current Ratio
4.384.384.913.667.357.41
Upgrade
Return on Equity (ROE)
-134.94%-134.94%-142.49%-107.91%-123.34%-339.20%
Upgrade
Return on Assets (ROA)
-53.18%-53.18%-53.15%-42.73%-53.91%-99.87%
Upgrade
Return on Capital (ROIC)
-85.95%-85.95%-94.70%-66.28%-77.75%-204.13%
Upgrade
Earnings Yield
-49.15%-50.64%-86.33%-52.20%-32.72%-50.31%
Upgrade
FCF Yield
-47.66%-49.11%-95.47%-55.47%-25.60%-42.11%
Upgrade
Buyback Yield / Dilution
-70.22%-70.22%-56.71%-47.49%-54.31%-317.19%
Upgrade
Updated Aug 29, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.